Skip to main content
MarketsSingle-sourceLow
2.1

Isofol Medical reports Q2 2026 operating loss of 16.3 million SEK

Isofol Medical's operating loss widened to 16.3 million SEK in Q2 2026 compared to 15.0 million SEK in the same period last year. The company maintains a strategy of accelerating development despite ongoing negative cash flow.

Dagens Industriabout 19 hours agoSECredibility 28%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

Locations

Gothenburg

Entities

country
Source

Related signals

8 found